Name | Company | Phase | Antigen |
---|---|---|---|
Affitope AD02 | Affiris/GlaxoSmithKline | 2 | Aβ1–6 |
CAD106 | Novartis | 2 | Aβ1–6 |
Vanutide cridificar | Elan/Johnson & Johnson/Pfizer Inc. | 2 | Aβ1–6 |
ACI24 | AC Immune/Bayer Healthcare Pharmaceuticals | 1/2 | Aβ1–15 |
V950 | Merck & Co. | 1 | Not published |
Affitope AD03 | Affiris/GlaxoSmithKline | 1 | Pyroglutamate modified Aβ |
UB311 | United Biomedical | 1 | Aβ1–14 |
AN1792 | Elan | Terminated | Aβ1–42 |